Pharmabiz7h
Dizal seeks US FDA approval for sunvozertinib to treat relapsed or refractory NSCLC with EGFR Exon 20 insertion mutations
Dizal seeks US FDA approval for sunvozertinib to treat relapsed or refractory NSCLC with EGFR Exon 20 insertion mutations: Shanghai, China Saturday, November 9, 2024, 17:00 Hrs [I ...
Pharmabiz6h
SpringWorks to present long-term efficacy and safety data from phase 3 DeFi trial of Ogsiveo in adults with desmoid tumours at CTOS 2024 meeting
SpringWorks to present long-term efficacy and safety data from phase 3 DeFi trial of Ogsiveo in adults with desmoid tumours at CTOS 2024 meeting ...
Pharmabiz9h
Adaptive Biotechnologies get expanded medicare coverage of clonoSEQ for assessing measurable residual disease in mantle cell lymphoma
Adaptive Biotechnologies get expanded medicare coverage of clonoSEQ for assessing measurable residual disease in mantle cell lymphoma: Seattle Saturday, November 9, 2024, 15:00 Hr ...
Pharmabiz11h
AskBio receives US FDA rare paediatric disease & orphan-drug designations for AB-1003 to treat limb-girdle muscular dystrophy type 2I/R9
Research Triangle Park, North Carolina Saturday, November 9, 2024, 13:00 Hrs [IST] ...
Pharmabiz8h
Serres Group receives €1.8 million research grant from Business Finland
Serres Group receives €1.8 million research grant from Business Finland: Espoo, Finland Saturday, November 9, 2024, 16:00 Hrs [IST] Serres has been granted a substantial researc ...
Pharmabiz10h
Transgene & NEC to present new data confirming clinical proof of principle for neoantigen cancer vaccine, TG4050, in head & neck cancer at SITC 2024
Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation, a leader in IT, network and AI technologies, announced 24.1 month ...
Pharmabiz12h
MGI Tech partners with Human Cell Atlas to advance human cell mapping efforts globally
MGI Tech partners with Human Cell Atlas to advance human cell mapping efforts globally: Shenzhen, China Saturday, November 9, 2024, 12:00 Hrs [IST] MGI Tech Co., Ltd, a company co ...
Pharmabiz15h
US FDA grants 510(k) clearance to Bayer’s MEDRAD Centargo CT Injection System
US FDA grants 510(k) clearance to Bayer’s MEDRAD Centargo CT Injection System: Berlin Saturday, November 9, 2024, 09:00 Hrs [IST] Bayer, a global enterprise with core competenci ...
Pharmabiz11h
KPPA to organize webinar series from November 17 to 23 as part of NPW celebration
As part of the National Pharmacy Week (NPW) celebration, the Kerala Private Pharmacist Association (KPPA) is organizing a high-impact webinar series from November 17th to 23rd, connected by the common ...
Pharmabiz16h
National online certificate course for pathologists on cervical cancer screening to begin from November 25
National online certificate course for pathologists on cervical cancer screening to begin from November 25: Shardul Nautiyal, Mumbai Saturday, November 9, 2024, 08:00 Hrs [IST] Th ...
Pharmabiz16h
ICMR announces call for CAR proposals under extramural research programme
ICMR announces call for CAR proposals under extramural research programme: Shardul Nautiyal, Mumbai Saturday, November 9, 2024, 08:00 Hrs [IST] The Indian Council of Medical Resea ...
Pharmabiz1d
FOPE spots potential opportunities for Indian cos in Australia & ECTA seen to propel easy market access
The Federation of Pharmaceutical Entrepreneurs (FOPE) has identified potential opportunities for Indian pharmaceutical ...